Cagrilintide 10 mg is a long-acting amylin analogue under investigation in metabolic and satiety research. Amylin pathway research is a key area of study alongside incretin-based peptides.
Research Profile
- Long-acting amylin analogue
- Studied in satiety, gastric-emptying, and metabolic research models
- Often researched in combination with GLP-1 pathway compounds
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: Cagrilintide
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
